Sonnet BioTherapeutics Stock (NASDAQ: SONN) stock price, news, charts, stock research, profile.
You can purchase shares of Sonnet BioTherapeutics (NASDAQ:SONN) through any online brokerage.
Other companies in Sonnet BioTherapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Sonnet BioTherapeutics has a consensus price target of $10.18.
The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $1.48 last updated February 20, 2025 at 8:00 AM EST.
There are no upcoming dividends for Sonnet BioTherapeutics.
Sonnet BioTherapeutics’s Q2 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Sonnet BioTherapeutics.
Sonnet BioTherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.